| (S)-nicotine | decreases expression | EXP | | 6480464 | Nicotine results in decreased expression of MYO5B mRNA | CTD | PMID:17997037 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MYO5B mRNA | CTD | PMID:15034205 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:621347 | 6480464 | 2,6-dinitrotoluene affects the expression of MYO5B mRNA | CTD | PMID:21346803 |
| aflatoxin B1 | decreases expression | ISO | RGD:736652 | 6480464 | Aflatoxin B1 results in decreased expression of MYO5B mRNA | CTD | PMID:21641981 |
| all-trans-retinoic acid | increases expression | ISO | RGD:736652 | 6480464 | Tretinoin results in increased expression of MYO5B mRNA | CTD | PMID:21934132 |
| ammonium chloride | affects expression | ISO | RGD:621347 | 6480464 | Ammonium Chloride affects the expression of MYO5B mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:736652 | 6480464 | Benzo(a)pyrene results in decreased expression of MYO5B mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MYO5B mRNA | CTD | PMID:15034205 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of MYO5B mRNA] | CTD | PMID:15034205 |
| benzo[a]pyrene | decreases expression | ISO | RGD:736652 | 6480464 | Benzo(a)pyrene results in decreased expression of MYO5B mRNA | CTD | PMID:20106945 PMID:21632981 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of MYO5B mRNA | CTD | PMID:21715664 |
| calcitriol | increases expression | ISO | RGD:736652 | 6480464 | Calcitriol results in increased expression of MYO5B mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:736652 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of MYO5B mRNA | CTD | PMID:21592394 |
| coumestrol | multiple interactions | ISO | RGD:736652 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MYO5B mRNA | CTD | PMID:19167446 |
| diarsenic trioxide | increases expression | ISO | RGD:736652 | 6480464 | arsenic trioxide results in increased expression of MYO5B mRNA | CTD | PMID:22521957 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of MYO5B mRNA | CTD | PMID:21266533 |
| ethanol | multiple interactions | ISO | RGD:621347 | 6480464 | [Fish Oils co-treated with Ethanol] results in increased expression of MYO5B mRNA | CTD | PMID:17347304 |
| kainic acid | decreases expression | EXP | | 6480464 | Kainic Acid results in decreased expression of MYO5B mRNA | CTD | PMID:17997037 |
| methamphetamine | affects response to substance | ISO | RGD:736652 | 6480464 | MYO5B gene SNP affects the susceptibility to Methamphetamine | CTD | PMID:18316681 |
| paracetamol | decreases expression | ISO | RGD:736652 | 6480464 | Acetaminophen results in decreased expression of MYO5B mRNA | CTD | PMID:21420995 |
| perfluorooctanoic acid | increases expression | ISO | RGD:621347 | 6480464 | perfluorooctanoic acid results in increased expression of MYO5B mRNA | CTD | PMID:16221955 PMID:19162173 |
| perfluorooctanoic acid | increases expression | ISO | RGD:621347 | 6480464 | perfluorooctanoic acid results in increased expression of MYO5B mRNA | CTD | PMID:19162173 PMID:16221955 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MYO5B mRNA] | CTD | PMID:19482888 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MYO5B mRNA | CTD | PMID:19482888 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MYO5B mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MYO5B mRNA | CTD | PMID:20059764 PMID:18301758 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of MYO5B mRNA] | CTD | PMID:20059764 |
| pirinixic acid | increases expression | ISO | RGD:621347 | 6480464 | pirinixic acid results in increased expression of MYO5B mRNA | CTD | PMID:19162173 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MYO5B mRNA | CTD | PMID:18301758 PMID:20059764 |
| testosterone | increases expression | ISO | RGD:736652 | 6480464 | Testosterone results in increased expression of MYO5B mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | ISO | RGD:736652 | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of MYO5B mRNA | CTD | PMID:21592394 |
| trimellitic anhydride | decreases expression | EXP | | 6480464 | trimellitic anhydride results in decreased expression of MYO5B mRNA | CTD | PMID:19042947 |